Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 42 of Larimar Therapeutics, Inc.'s SEC filings and found 1 convertible, 1 ATM program, 1 shelf registration and 4 completed offerings on file for LRMR. The latest dilution event on file is ATM sales on Aug 4, 2026. Analysis updated Oct 31, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
QTTBQ32 Bio Inc.
LYELLyell Immunopharma, Inc.
LCTXLineage Cell Therapeutics, Inc.
LXEOLexeo Therapeutics, Inc. Common Stock
OCGNOcugen, Inc.
BIOABioAge Labs Inc.
CAMPCAMP4 Therapeutics Corporation
FATEFate Therapeutics, Inc.
IPSCCentury Therapeutics, Inc.
ABEOAbeona Therapeutics Inc.
CABACabaletta Bio, Inc.
IFRXInflaRx N.V. Common Stock
GLSIGreenwich LifeSciences, Inc.
FULCFulcrum Therapeutics, Inc.
IMRXImmuneering Corporation